References
- Nishijo J., Nagai M., Yasuda M., Ohno E., Ushiroda Y. Interaction of 6‐p‐toluidinylnaphthalene‐2‐sulfonate with beta‐cyclodextrin. J. Pharm. Sci. 1995; 84(12)1420–1426
- Moyano J. R., Arias‐Blanco M. J., Gaines J. M., Rabasco J. I., Perez‐Martonez M., Giordano F. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta‐cyclodextrin. J. Pharm. Sci. 1997; 86(1)72–75
- Linares M., de Bertorello M. M., Longhi M. Solubilization of naphthioquinones by complexation with hydroxypropyl‐beta‐cyclodextrin. Int. J. Pharm. 1997; 159: 13–18
- Casella R., Williams D. A., Jambhekar S. S. Solid state beta‐cyclodextrin complexes containing indomethacin, ammonia and water. II. Solubility studies. Int. J. Pharm. 1998; 165: 15–22
- Dalmona M. E.A., Oliveira A. G. Inclusion complex of piroxicam with beta‐cyclodextrin and incorporation in hexadecyltrimethyl ammonium bromide based microemulsion. Int. J. Pharm. 1999; 184: 157–164
- Dollo G., Le Corre P., Chollet M., Chevanne F., Bertault M., Burgot J. L., Le Verge R. Improvement in solubility and dissolution rate of 1,2‐dithiole‐3‐thiones upon complexation with beta‐cyclodextrin and its hydroxypropyl and sulfobutyl ether‐7 derivatives. J. Pharm. Sci. 1999; 88(9)889–895
- Choudhury S., Nelson K. F. Improvement of oral bioavailability of carbamazepine by inclusion in 2‐hydroxy beta‐cyclodextrin. The 6th International Symposium on Cyclodextrin. Ed. Sante, ParisFrance 1992
- Hoshino T., Uekama K., Pitha J. Increase in temperature enhances solubility of drugs in aqueous solutions of hydroxypropyl cyclodextrins. Int. J. Pharm. 1993; 98(1–3)239–242
- Higuchi T., Connors K. A. Phase‐solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4: 117–212